← Back to Clinical Trials
Recruiting NCT07469215

NCT07469215 Behavioral Parent Training With and Without AI Support for Children With Disruptive Behaviors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07469215
Status Recruiting
Phase
Sponsor Fundació Sant Joan de Déu
Condition Behavior Problem of Childhood and Adolescence
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-04
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Behavioral Parent Training (BPT)Behavioral Parent Training (BPT) + Support of AI app

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-04 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn if adding an artificial intelligence (AI) application called to standard Behavioral Parent Training (BPT) helps families with children who have disruptive behavior problems. It will also help researchers understand if the app is easy to use and helpful for parents. The main question it aims to answer is: \- Is it feasible and acceptable for parents to use the AI app alongside their therapy sessions? The secondary questions it aims to answer are: * Does the app help reduce children's disruptive behaviors and irritability more than therapy alone? * Does using the app help lower stress, anxiety, and depression levels for the parents? Researchers will compare: 1. Standard BPT: Parents receive 8 weekly group training sessions (online). 2. BPT plus ParenteAI: Parents receive the same 8 weekly sessions plus 24/7 access to an AI virtual assistant for personalized support. Participants will: * Attend 8 weekly group training sessions. * Complete surveys about their child's behavior and their own well-being at baseline, after group training sessions 4 and 8, and 3 and 6 months after finalizing the group training. * If in the experimental group, use the ParenteAI app to get real-time coaching and support for managing their child's behavior at home. * Provide feedback on their experience and satisfaction with the program.

Eligibility Criteria

Inclusion Criteria: * Being a primary caregiver with a child aged 5 to 12 years exhibiting disruptive behaviors (e.g., symptoms of ODD, CD, IED, ADHD, and/or unspecified behavioral problems). * Having access to an electronic device and regular internet access. * Stable concomitant intervention including medications throughout the study. * Speak Spanish or Catalan language. * Signed informed consent by parents or legal guardians of the child. Exclusion Criteria: * Having ASD as primary diagnosis. * Psychosis, self-harming behaviors, severe mood disorder. * Known Intelligent quotient \< 70 * Caregivers and/or children receiving any concurrent psychological treatment. * No signing the informant consent.

Contact & Investigator

Central Contact

Pablo Vidal-Ribas Belil, PhD

✉ pablo.vidalribas@sjd.es

📞 +34644890465

Principal Investigator

Pablo Vidal-Ribas Belil, PhD

PRINCIPAL INVESTIGATOR

Fundació de Recerca Sant Joan de Déu

Frequently Asked Questions

Who can join the NCT07469215 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 12 Years, studying Behavior Problem of Childhood and Adolescence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07469215 currently recruiting?

Yes, NCT07469215 is actively recruiting participants. Contact the research team at pablo.vidalribas@sjd.es for enrollment information.

Where is the NCT07469215 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT07469215 clinical trial?

NCT07469215 is sponsored by Fundació Sant Joan de Déu. The principal investigator is Pablo Vidal-Ribas Belil, PhD at Fundació de Recerca Sant Joan de Déu. The trial plans to enroll 40 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology